Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1987 Oct;70(1):192–200.

Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies.

P L Tazzari 1, M Gobbi 1, A Dinota 1, A Bontadini 1, G Grassi 1, C Cerato 1, M Cavo 1, S Pileri 1, F Caligaris-Cappio 1, S Tura 1
PMCID: PMC1542220  PMID: 3319299

Abstract

Three monoclonal antibodies (MoAb), named 8A, 8F6 and 62B1, reacting with plasma cell-associated antigens, were characterized. 8A was found to be positive throughout the B cell lineage maturation steps from the immature B-committed CD10+ cell to the plasma cells. 8F6 and 62B1 reactivity is restricted to more mature cells and related lymphoid malignancies. In particular 62B1 appears to be limited to hairy cells and plasma cells. The results show that it is possible to obtain reagents reacting with plasma cells by immunizing mice with cells derived from human multiple myelomas. Furthermore, the obtained results suggest that it is possible to elicit antibodies against antigens which are present throughout all the differentiation steps of the B cell lineage. These new MoAb could help in elucidating the phenotype of the plasma cells and the relationships of multiple myelomas with other B cell proliferative disorders.

Full text

PDF
192

Images in this article

195Fig. 1
on p.195

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdou N. I., Abdou N. L. The monoclonal nature of lymphocytes in multiple myeloma. Effects of therapy. Ann Intern Med. 1975 Jul;83(1):42–45. doi: 10.7326/0003-4819-83-1-42. [DOI] [PubMed] [Google Scholar]
  2. Anderson K. C., Bates M. P., Slaughenhoupt B. L., Pinkus G. S., Schlossman S. F., Nadler L. M. Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood. 1984 Jun;63(6):1424–1433. [PubMed] [Google Scholar]
  3. Anderson K. C., Bates M. P., Slaughenhoupt B., Schlossman S. F., Nadler L. M. A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells. J Immunol. 1984 Jun;132(6):3172–3179. [PubMed] [Google Scholar]
  4. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976 Aug;33(4):451–458. doi: 10.1111/j.1365-2141.1976.tb03563.x. [DOI] [PubMed] [Google Scholar]
  5. Bhan A. K., Nadler L. M., Stashenko P., McCluskey R. T., Schlossman S. F. Stages of B cell differentiation in human lymphoid tissue. J Exp Med. 1981 Sep 1;154(3):737–749. doi: 10.1084/jem.154.3.737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Burns G. F., Worman C. P., Roberts B. E., Raper C. G., Barker C. R., Cawley J. C. Terminal B cell development as seen in different human myelomas and related disorders. Clin Exp Immunol. 1979 Feb;35(2):180–189. [PMC free article] [PubMed] [Google Scholar]
  7. Caligaris-Cappio F., Bergui L., Tesio L., Pizzolo G., Malavasi F., Chilosi M., Campana D., van Camp B., Janossy G. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. J Clin Invest. 1985 Sep;76(3):1243–1251. doi: 10.1172/JCI112080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Catovsky D., Linch D. C., Beverley P. C. T cell disorders in haematological diseases. Clin Haematol. 1982 Oct;11(3):661–695. [PubMed] [Google Scholar]
  9. Gobbi M., Caligaris-Cappio F., Campana D., Tazzari P. L., Bergui L., Cavo M., Tura S. Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen. Clin Exp Immunol. 1984 Dec;58(3):625–630. [PMC free article] [PubMed] [Google Scholar]
  10. Gobbi M., Caligaris-Cappio F., Janossy G. Normal equivalent cells of B cell malignancies: analysis with monoclonal antibodies. Br J Haematol. 1983 Jul;54(3):393–403. doi: 10.1111/j.1365-2141.1983.tb02114.x. [DOI] [PubMed] [Google Scholar]
  11. Gonchoroff N. J., Katzmann J. A., Garton J. P., Ruiz-Argüelles G. J., Eilers C. R., Greipp P. R., Kyle R. A. A monoclonal antibody reactive with a subset of human plasma cells. Br J Haematol. 1986 Apr;62(4):619–630. doi: 10.1111/j.1365-2141.1986.tb04084.x. [DOI] [PubMed] [Google Scholar]
  12. Halper J., Fu S. M., Wang C. Y., Winchester R., Kunkel H. G. Patterns of expression of human "Ia-like" antigens during the terminal stages of B cell development. J Immunol. 1978 May;120(5):1480–1484. [PubMed] [Google Scholar]
  13. Harris N. S. Plasma cell surface antigen on human blood lymphocytes. Nature. 1974 Aug 9;250(5466):507–509. doi: 10.1038/250507a0. [DOI] [PubMed] [Google Scholar]
  14. Janossy G., Prentice H. G. T cell subpopulations, monoclonal antibodies and their therapeutic applications. Clin Haematol. 1982 Oct;11(3):631–660. [PubMed] [Google Scholar]
  15. Katagiri S., Yonezawa T., Tamaki T., Kanayama Y., Kuyama J., Ohnishi M., Tsubakio T., Kurata Y., Tarui S. Surface expression of human myeloma cells: an analysis using a panel of monoclonal antibodies. Acta Haematol. 1984;72(6):372–378. doi: 10.1159/000206423. [DOI] [PubMed] [Google Scholar]
  16. Kubagawa H., Vogler L. B., Capra J. D., Conrad M. E., Lawton A. R., Cooper M. D. Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation. J Exp Med. 1979 Oct 1;150(4):792–807. doi: 10.1084/jem.150.4.792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mackenzie M. R., Paglieroni T. G. Plasma cell antigens in human multiple myeloma. J Lab Clin Med. 1977 May;89(5):1009–1017. [PubMed] [Google Scholar]
  18. Pilarski L. M., Mant M. J., Ruether B. A. Pre-B cells in peripheral blood of multiple myeloma patients. Blood. 1985 Aug;66(2):416–422. [PubMed] [Google Scholar]
  19. Ruiz-Argüelles G. J., Katzmann J. A., Greipp P. R., Gonchoroff N. J., Garton J. P., Kyle R. A. Multiple myeloma: circulating lymphocytes that express plasma cell antigens. Blood. 1984 Aug;64(2):352–356. [PubMed] [Google Scholar]
  20. Sandhaus L. M., Gajl-Peczalska K. J., Brunning R. D. Immunophenotyping of leukaemia: an immunoperoxidase method using air-dried smears. Br J Haematol. 1984 Jan;56(1):131–138. doi: 10.1111/j.1365-2141.1984.tb01278.x. [DOI] [PubMed] [Google Scholar]
  21. Schroff R. W., Foon K. A., Billing R. J., Fahey J. L. Immunologic classification of lymphocytic leukemias based on monoclonal antibody-defined cell surface antigens. Blood. 1982 Feb;59(2):207–215. [PubMed] [Google Scholar]
  22. Stein H., Gerdes J., Mason D. Y. The normal and malignant germinal centre. Clin Haematol. 1982 Oct;11(3):531–559. [PubMed] [Google Scholar]
  23. Van Camp B., Reynaert P., Broodtaerts L. Studies on the origin of the precursor cells in multiple myeloma, Waldenström's macroglobulinaemia and benign monoclonal gammopathy. I. Cytoplasmic isotype and idiotype distribution in peripheral blood and bone marrow. Clin Exp Immunol. 1981 Apr;44(1):82–89. [PMC free article] [PubMed] [Google Scholar]
  24. Vogler L. B. Bone marrow B cell development. Clin Haematol. 1982 Oct;11(3):509–529. [PubMed] [Google Scholar]
  25. Weiss L. M., Bindl J. M., Picozzi V. J., Link M. P., Warnke R. A. Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Blood. 1986 Feb;67(2):474–478. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES